SP

Stelios Papadopoulos

Europe, Germany

Description

Stelios Papadopoulos, Ph.D., a co-founder of Exelixis, has been a director since December 1994 and the Chairman of the Board since January 1...

Investor Profile

Stelios Papadopoulos has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stelios Papadopoulos frequently co-invest with?

HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 1
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 1
LB
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
VM
North America, Alabama, United States, Birmingham
Co-Investments: 1
Prospect Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
Venrock
North America, California, United States, Palo Alto
Co-Investments: 1
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Stelios Papadopoulos often collaborate with?

FM
North America, United States
Shared Deals: 1
SH
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Stelios Papadopoulos?

Infinity Pharmaceuticals

Cambridge, Massachusetts, United States

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

BiopharmaBiotechnologyPharmaceutical
Series BJun 24, 2002
Amount Raised: $70,000,000